IL2RA and neoplasm: Vargas et al. found that the widely used anti-CD25 antibody (PC-61, αCD25-r1) almost exclusively kills peripheral Tregs and does not effectively inhibit tumor infiltrating Tregs because of high intra-tumoral expression of FcγRIIb.